Appropriateness of Colonoscopy Indication: an Evaluation of the Clinical and Economic Impact.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
About this trial
The aim of the study is to evaluate the appropriateness of colonoscopy prescription and the impact of colonoscopies in diagnostic performance in order to develop and validate a predictive model for selecting patients most likely to present with significant lesions and thus lower costs and waiting lists.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age >18 years
Patients undergoing outpatient and inpatient colonoscopy for any pathology, as part of the normal care process
Obtaining informed consent.
Disqualifiers
Investigations performed in an emergency/emergency setting
Trial population
Participating subjects will undergo data collection at the same time as colonoscopy. After enrollment, information will be collected for each included patient regarding the demographic and clinical characteristics, the reason for prescription, and the diagnostic question proposed in congruity with EPAGE/ASGE criteria.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
1,410 Participants
are grouped into 1 trial groupGroup A: Data collection for each patient on endoscopic examination
Trial outcomes
Primary outcomes
1
Number of colonoscopies
Define the number of colonoscopies with indication appropriate out of the total number of colonoscopies performed, and quantify clinically relevant lesions and CCRs in appropriate and inappropriate colonoscopies.
Time frame
5 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov